Colon cancer research

RGI is focused on colon cancer research. We have recently transfected several colon cancer cell lines with the genes for luciferase, green fluorescent protein and red fluorescent protein. We are utilizing these cell lines to search for a drug that will attack these cells specifically while leaving the normal cells in the body intact and unharmed. By using this method, we can find drugs will cure a patient’s cancer while not subjecting the patient to the destructive effects of standard chemotherapy. Please contact us for details about this exciting project.